Kaplan-Meier analysis of expression cohorts of breast tumors showed that high NUPR1 mRNA expression levels correlate with poor overall and relapse-free survival in both endocrine therapy-treated ER+ and ERBB2-enriched breast cancer patients. Here, NUPR1 is linked to breast cancer.